Population
7 juvenile rhesus monkeys (6 infected with SIVagmTYO-1, 5, or 7; 1 infected with SIVsmm)
Design
Preclinical
Follow-up
Up to 44 weeks
Authors
Loading...
May support SIVagm rhesus model for HIV; leaves open validation for human vaccine translation.
Rhesus monkeys infected with SIVagm can serve as an animal model for studying HIV infection and vaccine trials.
Herchenröder et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: